Adil Abbasi, MD FACP

Learning Objectives

• Understand the diagnostic criteria for SIADH
• Differentiate SIADH from other causes of hyponatremia
• Interpret serum and urine studies in the evaluation of SIADH
• Recognize key clinical and laboratory features
• Apply a stepwise diagnostic algorithm in clinical practice
• Identify common pitfalls and mimics of SIADH

Introduction

The syndrome of inappropriate antidiuretic hormone secretion (SIADH) is a common cause of euvolemic hyponatremia characterized by impaired free water excretion due to inappropriately elevated antidiuretic hormone (ADH) activity. Despite normal or increased total body water, patients appear clinically euvolemic because excess water distributes across intracellular and extracellular compartments without causing overt edema.

The diagnosis of SIADH is fundamentally a diagnosis of exclusion, requiring careful assessment of volume status, laboratory parameters, and elimination of other causes of hyponatremia such as adrenal insufficiency, hypothyroidism, and renal failure.

____________________________________________________________________________________

Common Causes of SIADH (Etiologic Clues)

Although diagnosis is biochemical, identifying the cause is critical.

Central Nervous System Disorders

Stroke, hemorrhage, trauma, infections

Pulmonary Disorders

Pneumonia, tuberculosis

Malignancies

Especially small-cell lung carcinoma (ectopic ADH production)

Medications

SSRIs, carbamazepine, cyclophosphamide, antipsychotics

Core Diagnostic Criteria

The classic diagnostic criteria for SIADH (modified from Bartter and Schwartz) include the following essential components:

Table 1. Diagnostic Criteria for SIADH

These criteria emphasize that SIADH is characterized by hypotonic hyponatremia with inappropriately concentrated urine in the absence of physiologic stimuli for ADH release.

Stepwise Diagnostic Approach

A structured approach is essential to avoid misdiagnosis.

Step 1: Confirm True Hyponatremia

Measure serum osmolality to exclude:

• Isotonic hyponatremia (pseudohyponatremia due to hyperlipidemia or hyperproteinemia)
• Hypertonic hyponatremia (e.g., hyperglycemia)

Only hypotonic hyponatremia should prompt evaluation for SIADH.

Step 2: Assess Volume Status

Clinical examination should confirm euvolemia, characterized by:

• Absence of edema
• No signs of dehydration (no orthostatic hypotension, dry mucosa)
• Normal skin turgor

This step differentiates SIADH from:

• Hypovolemic hyponatremia (e.g., GI losses, diuretics)
• Hypervolemic hyponatremia (e.g., heart failure, cirrhosis)

Step 3: Urine Studies

Urine findings are central to diagnosis.

• Urine osmolality >100 mOsm/kg indicates inappropriate concentration of urine
• Urine sodium >30–40 mEq/L reflects renal sodium excretion despite hyponatremia

In SIADH, the kidney fails to appropriately dilute urine despite low serum osmolality.

Step 4: Exclude Endocrine Causes

Before diagnosing SIADH, exclude:

• Adrenal insufficiency (e.g., Addison’s disease)
• Hypothyroidism

Both conditions can mimic SIADH by increasing ADH activity.

Step 5: Assess Renal Function

Normal renal function is required for the diagnosis. Renal failure can impair free water excretion and mimic SIADH.

Laboratory Features

Table 2. Typical Laboratory Findings in SIADH

Low uric acid and BUN reflect dilutional effects and increased renal excretion.

Differentiating SIADH from Other Causes

Table 3. Key Differentiating Features

Special Diagnostic Considerations

SIADH vs. Cerebral Salt Wasting

Both present with hyponatremia and high urine sodium, but:

• SIADH: euvolemic
• Cerebral salt wasting: hypovolemic

SIADH in Older Adults

Diagnosis is more challenging due to:

• Subtle volume findings
• Polypharmacy
• Coexisting diseases

Pitfalls in Diagnosis

• Misinterpreting volume status (most common error)
• Failure to exclude adrenal insufficiency
• Overlooking medication-induced SIADH
• Confusing SIADH with diuretic-induced hyponatremia

Principles of Management

The fundamental goals of treatment include:

• Stabilization of the patient and prevention of neurologic complications
• Gradual correction of serum sodium
• Identification and treatment of the underlying cause
• Prevention of recurrence

A key concept is that overcorrection is more dangerous than undercorrection, as it may lead to osmotic demyelination syndrome.

Assessment-Based Approach

Table 1. Management Based on Severity

Management of Acute Symptomatic SIADH

Acute hyponatremia (developing within <48 hours) with severe neurologic symptoms requires urgent correction.

Hypertonic Saline (3%)

Hypertonic saline is the treatment of choice. Small boluses are typically administered to raise serum sodium by 4–6 mEq/L rapidly to alleviate life-threatening cerebral edema.

Typical approach:

• 100 mL of 3% saline over 10 minutes
• May repeat up to 2–3 times as needed

Close monitoring of serum sodium is essential, usually every 2–4 hours.

Management of Chronic or Mild SIADH

1. Fluid Restriction (First-Line Therapy)

Fluid restriction is the cornerstone of treatment.

• Typical restriction: 800–1200 mL/day
• More stringent restriction may be required in severe cases

This reduces free water intake and allows gradual correction of sodium.

2. Increase Solute Intake

Increasing dietary solute enhances renal free water excretion.

• Oral salt tablets
• High-protein diet
• Urea (in selected patients)

3. Loop Diuretics with Salt

Loop diuretics (e.g., furosemide) reduce renal concentrating ability, promoting free water excretion. These are often combined with salt supplementation to prevent further sodium loss.

Pharmacologic Therapy

Pharmacologic therapy is considered when fluid restriction is ineffective or poorly tolerated.

Table 2. Pharmacologic Options

Vasopressin Receptor Antagonists (Vaptans)

These agents block ADH action in the kidney, increasing free water excretion without affecting sodium.

Tolvaptan is commonly used but requires monitoring due to risks of:

• Overcorrection
• Hepatotoxicity (with long-term use)

Demeclocycline

Induces a form of nephrogenic diabetes insipidus, reducing responsiveness to ADH. Its use is limited due to nephrotoxicity and delayed onset.

Rate of Correction

Safe correction limits are critical.

Table 3. Recommended Correction Rates

High-risk patients include those with alcoholism, malnutrition, liver disease, or hypokalemia.

Prevention of Overcorrection

Overcorrection may occur due to spontaneous water diuresis once ADH levels fall.

Preventive strategies include:

• Frequent sodium monitoring
• Use of desmopressin (DDAVP) to control rapid correction
• Administration of free water (D5W) if overcorrection occurs

Management of Underlying Causes

Effective treatment requires identification and correction of the underlying cause.

Common Interventions

• Discontinuation of offending medications (e.g., SSRIs, diuretics)
• Treatment of pulmonary or CNS disorders
• Management of malignancies producing ectopic ADH

Geriatric-Focused Approach

SIADH is particularly common in older adults and requires individualized management.

Fluid restriction may be difficult due to:

• Cognitive impairment
• Dependence on caregivers
• Risk of dehydration

Medication review is critical, as polypharmacy is a frequent cause.

Older adults are also at higher risk of complications from both hyponatremia and its treatment, including falls, fractures, and osmotic demyelination.

Complications of Treatment

Osmotic Demyelination Syndrome (ODS)

This is the most feared complication of rapid correction. It is characterized by demyelination in the central pontine region and presents with:

• Dysarthria
• Dysphagia
• Quadriparesis
• Locked-in syndrome

Prevention through controlled correction is essential.

Special Clinical Scenarios

SIADH with Severe Hypervolemia

Rare but may require combined strategies including diuretics and fluid restriction.

Refractory SIADH

May require combination therapy (fluid restriction + vaptans or urea).

Summary

SIADH is a diagnosis of hypotonic, euvolemic hyponatremia with inappropriately concentrated urine in the absence of renal, adrenal, or thyroid dysfunction. Diagnosis requires a structured, stepwise approach incorporating clinical assessment and targeted laboratory evaluation.

Recognition of SIADH is essential because management differs significantly from other causes of hyponatremia, and inappropriate treatment can lead to serious complications.

Management of SIADH requires a careful balance between correcting hyponatremia and avoiding complications. Acute symptomatic cases require prompt treatment with hypertonic saline, whereas chronic cases are managed primarily with fluid restriction and, when necessary, pharmacologic agents.

Safe correction limits are critical to prevent osmotic demyelination syndrome. Treatment of the underlying cause and individualized care, particularly in older adults, are essential for optimal outcomes.

References

Bartter, F. C., & Schwartz, W. B. (1967). The syndrome of inappropriate secretion of antidiuretic hormone. American Journal of Medicine, 42(5), 790–806.

Ellison, D. H., & Berl, T. (2007). The syndrome of inappropriate antidiuresis. New England Journal of Medicine, 356(20), 2064–2072.

Spasovski, G., et al. (2014). Clinical practice guideline on diagnosis and treatment of hyponatraemia. Nephrology Dialysis Transplantation, 29(Suppl 2), i1–i39.

Sterns, R. H. (2015). Disorders of plasma sodium. New England Journal of Medicine, 372(1), 55–65.

Verbalis, J. G., et al. (2013). Diagnosis, evaluation, and treatment of hyponatremia. American Journal of Medicine, 126(10), S1–S42.